Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 140 participants.
Also called NCT03114995
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 140 participants
- Registry
-
NCT03114995
-
- Other papers using this trial's data
- Effect of tailored use of tirofiban in patients with Non-ST-elevation acute coronary syndrome undergoing percutaneous coronary intervention: a randomized controlled trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT03114995. Randomized; double masking; primary purpose treatment. Start 2012-02-01 (actual); primary completion 2015-10-01 (actual). Results posted on 2018-06-08.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tailored Use of Tirofiban for Non-ST-elevation Acute Coronary Syndrome Patients
- Condition
- Non-ST Elevation Myocardial Infarction
- Intervention (Drug)
- Tirofiban
- Lead sponsor
- Seoul National University Bundang Hospital
Record details
- Record id
cardio:ct-nct03114995- Content hash
891f103ed217feb1eb3b004b8d38272a67f1219b8d6e5db0f2d0a48024c59372